BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7192154)

  • 21. Influence of subclass-specific anti-idiotypic antibodies on the kinetics of the immune response to BCG.
    Daus H; Hammer HJ; Rajki K; Mauch H
    Immunology; 1984 Aug; 52(4):697-702. PubMed ID: 6611300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
    López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
    Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
    Kon S
    Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.
    Hough DW; Eady RP; Hamblin TJ; Stevenson FK; Stevenson GT
    J Exp Med; 1976 Oct; 144(4):960-9. PubMed ID: 62018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
    Gordon J; Anderson VA; Stevenson GT
    J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes.
    Stevenson FK; Hamblin TJ; Stevenson GT; Tutt AL
    J Exp Med; 1980 Dec; 152(6):1484-96. PubMed ID: 6969771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Substitution with immunoglobulins in leukemia].
    Schmitz N; Gassmann W; Löffler H
    Beitr Infusionther Klin Ernahr; 1982; 9():25-33. PubMed ID: 6756384
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen.
    Powell TJ; Spann R; Vakil M; Kearney JF; Lamon EW
    J Immunol; 1988 May; 140(9):3266-72. PubMed ID: 3258895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen-induced murine B-cell lymphomas. III. Passive anti-idiotype serum therapy and its combined effect with chemotherapy.
    Lanier LL; Babcock GF; Lynes MA; Haughton G
    J Natl Cancer Inst; 1979 Dec; 63(6):1417-22. PubMed ID: 316036
    [No Abstract]   [Full Text] [Related]  

  • 32. Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.
    Austin EB; Robins RA; Durrant LG; Price MR; Baldwin RW
    Immunology; 1989 Aug; 67(4):525-30. PubMed ID: 2788611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
    Raffeld M; Neckers L; Longo DL; Cossman J
    N Engl J Med; 1985 Jun; 312(26):1653-8. PubMed ID: 3923351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody therapy of lymphoid malignancy.
    Lowder JN; Meeker TC; Levy R
    Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.
    Stevenson FK; Glennie MJ; Johnston DM; Tutt AL; Stevenson GT
    Br J Cancer; 1984 Sep; 50(3):407-13. PubMed ID: 6380556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helper T lymphocytes from xid and normal mice support anti-phosphocholine antibody responses with equivalent T15, 511, and 603 idiotypic composition.
    Feeney AJ; Mosier DE
    J Immunol; 1984 Dec; 133(6):2868-73. PubMed ID: 6238089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional dichotomy of idiotypic expression on senescent B lymphocytes in systemic and mucosal immune systems: selective changes in NPb and T15 idiotypes with aging.
    Haq JA; Khan RH; Szewczuk MR
    Reg Immunol; 1992; 4(6):371-80. PubMed ID: 1297407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran.
    Schechter B; Pauzner R; Arnon R; Haimovich J; Wilchek M
    Cancer Immunol Immunother; 1987; 25(3):225-30. PubMed ID: 2445485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.